AI giant Anthropic has announced the discovery of a new enzyme system in bacterial DNA that it said could “represent a new gene editing mechanism” similar to the groundbreaking CRISPR tool. Anthropic said on Wednesday that its signature AI model, Claude, had “autonomously” discovered the system at the prompting of researchers working at the company’s recently established biology research lab in San Francisco. The tech giant said the system showed characteristics found in only a handful of other “programmable” structures and displayed a “pattern reminiscent of CRISPR”, a genome-editing mechanism found in bacteria. CRISPR technology has been credited with advancing the treatment of a range of diseases, including sickle cell disease and cancer.
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.